e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Novel approaches to human studies in allergy and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systemic coagulation increases with asthma severity
M. Sneeboer, C. Majoor, N. Fens, M. van de Pol, K. van der Sluijs, J. Meijers, P. W. Kamphuisen, R. Lutter, P. Sterk, E. Bel (Amsterdam, Groningen, Netherlands)
Source:
International Congress 2014 – Novel approaches to human studies in allergy and asthma
Session:
Novel approaches to human studies in allergy and asthma
Session type:
Oral Presentation
Number:
4841
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sneeboer, C. Majoor, N. Fens, M. van de Pol, K. van der Sluijs, J. Meijers, P. W. Kamphuisen, R. Lutter, P. Sterk, E. Bel (Amsterdam, Groningen, Netherlands). Systemic coagulation increases with asthma severity. Eur Respir J 2014; 44: Suppl. 58, 4841
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014
Investigating the role of BAFF in murine models of allergic asthma
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
The clinical and genetic factors for predicting the response to inhaled corticosteroids
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Pim1 kinase affects allergic asthma in a HDM-driven mice model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Evaluating omalizumab persistency of response after long-term therapy (XPORT)
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Features of asthma treatment while pregnancy
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Genetic polymorphisms in early and late-onset bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Research of an arterial rigidity in patients with bronchial asthma and accompanying arterial hypertension and BMI
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Duvelisib, a PI3K-δ,γ inhibitor, in subjects with mild asthma
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept